Pharmacyclics (PCYC-Free Report) was in the news last week with the company signing an agreement with Roche under which its cancer treatment, Imbruvica, will be evaluated in combination with Roche’s Gazyva (Read more
Now if we can come up with theory where AMBS gets a partnership with Roche because of our relationship with Pharmacyclics then Risk and JP can spin it into a "promise"?